| Functional polymorphisms of FAS and FASL gene and risk of breast cancer–pilot study of 134 cases M Hashemi, A Fazaeli, S Ghavami, E Eskandari-Nasab, F Arbabi, ... Plos one 8 (1), e53075, 2013 | 105 | 2013 |
| Association of C1q/TNF-related protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes mellitus R Fadaei, N Moradi, M Baratchian, H Aghajani, M Malek, AA Fazaeli, ... PloS one 11 (12), e0168773, 2016 | 89 | 2016 |
| Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran M Hashemi, E Eskandari-Nasab, A Fazaeli, A Bahari, NA Hashemzehi, ... DNA and cell biology 31 (5), 672-677, 2012 | 63 | 2012 |
| Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population M Hashemi, E Eskandari-Nasab, A Fazaeli, M Taheri, H Rezaei, ... Biomarkers in medicine 6 (6), 797-803, 2012 | 60 | 2012 |
| Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8− 652 6N ins/del promoter polymorphism (rs3834129) in breast cancer M Hashemi, E Eskandari-Nasab, A Fazaeli, H Rezaei, MA Mashhadi, ... Gene 505 (1), 176-179, 2012 | 50 | 2012 |
| Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer E Eskandari-Nasab, M Hashemi, H Rezaei, A Fazaeli, MA Mashhadi, ... Molecular biology reports 39, 10531-10539, 2012 | 37 | 2012 |
| Expression optimization, purification, and functional characterization of cholesterol oxidase from Chromobacterium sp. DS1 A Fazaeli, A Golestani, M Lakzaei, SS Rasi Varaei, M Aminian PloS one 14 (2), e0212217, 2019 | 33 | 2019 |
| Association of-607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran M Taheri, M Hashemi, E Eskandari-Nasab, A Fazaeli, F Arababi, ... Prague Med Rep 113 (3), 217-222, 2012 | 27 | 2012 |
| Genotyping of–374A/T,–429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast … M Hashemi, A Moazeni-Roodi, F Arbabi, A Fazaeli, EE Nasab, M Taheri, ... Nucleosides, Nucleotides and Nucleic Acids 31 (5), 401-410, 2012 | 23 | 2012 |
| A comparison of three strategies for biopanning of phage‐scFv library against diphtheria toxin M Lakzaei, MJ Rasaee, AA Fazaeli, M Aminian Journal of cellular physiology 234 (6), 9486-9494, 2019 | 13 | 2019 |
| Expression optimization of recombinant cholesterol oxidase in Escherichia coli and its purification and characterization A Fazaeli, A Golestani, M Lakzaei, SS Rasi Varaei, M Aminian AMB Express 8, 1-9, 2018 | 9 | 2018 |
| Association of FAS (− 607 A/G) and FAS Ligand (− 844 C/T) gene polymorphisms with breast cancer in Zahedan, Southeast Iran A Fazaeli, M Hashemi, F Arbabi, E Eskandari, M Taheri Clinical Biochemistry 44 (13), S276, 2011 | | 2011 |
| Association of FAS ligand promoter polymorphism (− 844 C> T) with non-alcoholic fatty liver disease in Zahedan, Southeast Iran M Hashemi, A Bahari, A Fazaeli, M Taheri Clinical Biochemistry-New York 44 (13), 2, 2011 | | 2011 |
| Association of FAS ligand promoter polymorphism (− 844 C> T) with non-alcoholic fatty liver disease in Zahedan, Southeast Iran EE Nasab, M Hashemi, A Bahari, A Fazaeli, M Taheri Clinical Biochemistry 13 (44), S275, 2011 | | 2011 |
